Skip to main content
. 2017 May 18;8(43):75445–75454. doi: 10.18632/oncotarget.17995

Figure 1. Preferred reporting items for systematic reviews and meta-analyses flow diagram depicting overview of study-selection process for studies reporting on C-reactive protein and risk of schizophrenia.

Figure 1